A 6-month, Open-label, Safety Trial Of Pregabalin In Adolescent Patients With Fibromyalgia
A 6-month, Open-label, Safety Trial Of Pregabalin In Adolescent Patients With Fibromyalgia
The main purpose of this study is to evaluate the long-term safety of pregabalin in adolescent patients who participated in the previous fibromyalgia study (A0081180) and who wish to recieve open-label pregabalin
Inclusion Criteria:
Exclusion Criteria:
Worcester, Massachusetts 01655, United States
Cincinnati, Ohio 45219, United States
Charleston, South Carolina 29425, United States
Secunderabad, Andhra Pradesh 500 003, India
Nagpur, Maharashtra 440010, India